These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26776968)

  • 1. Cell based assays for anti-Plasmodium activity evaluation.
    Mokgethi-Morule T; N'Da DD
    Eur J Pharm Sci; 2016 Mar; 84():26-36. PubMed ID: 26776968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.
    Delves MJ
    Future Med Chem; 2012 Dec; 4(18):2251-63. PubMed ID: 23234549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.
    Kato N; March S; Bhatia SN; Marti M
    Methods Mol Biol; 2018; 1787():41-52. PubMed ID: 29736708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen.
    Tanaka TQ; Guiguemde WA; Barnett DS; Maron MI; Min J; Connelly MC; Suryadevara PK; Guy RK; Williamson KC
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1389-97. PubMed ID: 25512421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the biology component of the drug discovery strategy for malaria eradication.
    Leroy D; Campo B; Ding XC; Burrows JN; Cherbuin S
    Trends Parasitol; 2014 Oct; 30(10):478-90. PubMed ID: 25131411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs.
    Bolscher JM; Koolen KM; van Gemert GJ; van de Vegte-Bolmer MG; Bousema T; Leroy D; Sauerwein RW; Dechering KJ
    J Antimicrob Chemother; 2015 May; 70(5):1357-66. PubMed ID: 25667405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplasmodial natural products: an update.
    Tajuddeen N; Van Heerden FR
    Malar J; 2019 Dec; 18(1):404. PubMed ID: 31805944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drug resistance: new treatments options for Plasmodium.
    Gamo FJ
    Drug Discov Today Technol; 2014 Mar; 11():81-88. PubMed ID: 24847657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRIMALDDI: platform technologies and novel anti-malarial drug targets.
    Vial H; Taramelli D; Boulton IC; Ward SA; Doerig C; Chibale K
    Malar J; 2013 Nov; 12():396. PubMed ID: 24498961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
    Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
    Sante; 2011; 21(3):133-42. PubMed ID: 22294247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum gametocytes: with a view to a kill.
    Butterworth AS; Skinner-Adams TS; Gardiner DL; Trenholme KR
    Parasitology; 2013 Dec; 140(14):1718-34. PubMed ID: 23953486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-cell in vitro screening for gametocytocidal compounds.
    Lucantoni L; Avery V
    Future Med Chem; 2012 Dec; 4(18):2337-60. PubMed ID: 23234555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays.
    D'Alessandro S; Camarda G; Corbett Y; Siciliano G; Parapini S; Cevenini L; Michelini E; Roda A; Leroy D; Taramelli D; Alano P
    J Antimicrob Chemother; 2016 May; 71(5):1148-58. PubMed ID: 26888912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.